Spectris ( (GB:SXS) ) has shared an update.
Spectris reported a challenging year in 2024 with a 7% decrease in sales on a like-for-like basis due to weakness across multiple end markets. Despite this, the company ended the year with a strong fourth quarter, showing signs of recovery with a 6% order growth. Spectris has implemented a Profit Improvement Programme expected to deliver £50 million in benefits over the next two years, supported by strategic acquisitions and operational improvements. The company remains optimistic about returning to growth in 2025, focusing on cash generation and leverage reduction.
More about Spectris
Spectris is a company that provides premium precision measurement solutions, combining technical expertise and deep domain knowledge to deliver critical insights. The company focuses on two key divisions, Spectris Scientific and Spectris Dynamics, which operate in technology-driven end markets with strong growth potential. Spectris holds leading market positions in premium segments and employs around 7,600 people across more than 30 countries.
YTD Price Performance: 15.95%
Average Trading Volume: 199,258
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £2.87B
See more insights into SXS stock on TipRanks’ Stock Analysis page.